Examiner: SUNSHINE, HANNAH LOUISE

Tech Center 1600 • Art Units: 1641 1644 1647

This examiner grants 68% of resolved cases

Performance Statistics

67.7%

Allow Rate

+7.7% vs TC avg

Total Applications

+14.1%

Interview Lift

1385

Avg Prosecution Days

Based on 31 resolved cases, 2023–2026

4.7%

§101 Eligibility

16.4%

§102 Novelty

28.5%

§103 Obviousness

30.2%

§112 Clarity

App #	Title	Status	Assignee
17777363	COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY	Non-Final OA	University of Massachusetts
18019460	ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS	Non-Final OA	Juno Therapeutics, Inc.
18271026	NATURAL KILLER CELLS ENGINEERED TO REDUCE OR ELIMINATE CBL-B AND USES THEREOF	Non-Final OA	City of Hope

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.